CRNX

CRINETICS PHARMACEUTICALS IN

Institutional Ownership · Q4 2025

Filing: Q4 2025

CRINETICS PHARMACEUTICALS IN (CRNX) is held by 233 institutional investors with combined holdings of $5.1B. Major holders include FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GRO.

💰 Dark Pool Activity 👤 Insider Trades

Institutional Holders

233

Total Value

$5.1B

Ownership %

104.5%

🏦 Top Institutional Holders

WELLINGTON MANAGEMENT GROUP LLP

8.0M shares

$374.2M

7.62% ownership

BlackRock, Inc. (BLK)

8.0M shares

$371.9M

7.58% ownership

FARALLON CAPITAL MANAGEMENT LLC

6.9M shares

$322.7M

6.58% ownership

📊 Financials

Income statement, balance sheet, and cash flow from SEC filings.

🏦 Browse Funds

See complete portfolios of top hedge funds.

🎯 AI Signals

Find stocks where multiple funds are accumulating.